Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
Status:
Active, not recruiting
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
Background and significance: Treatment with opioid pain medications (like hydrocodone and
morphine) is common for severe pain, but studies show these medications may not always help
and can cause serious problems. High daily doses of opioids can be especially unsafe. To help
patients with chronic pain have better quality of life and avoid medication toxicity, health
care teams need to manage pain while helping patients reduce opioid medication doses to safer
levels.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborator:
Patient-Centered Outcomes Research Institute
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone